Position in REGN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,169,137
-$528,353 QoQ
Shares Held
1,875
-14.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#616
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $57,798,048 across 32 Biotechnology names. REGN ranks #10 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
|
127,281 | $16,894,007 | |
| 2 | TECH |
BIO-TECHNE Corp
|
189,300 | $13,374,045 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
65,300 | $4,863,544 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,891 | $3,919,696 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
46,200 | $3,616,074 | |
| 6 | MRNA |
Moderna, Inc.
|
29,500 | $2,065,885 | |
| 7 | INCY |
Incyte Corp
|
14,197 | $1,609,371 | |
| 8 | ABVX |
Abivax S.A.
|
10,000 | $1,332,600 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,169,137 | 1,875 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $1,697,490 | 2,197 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,419,468 | 1,839 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,049,195 | 1,866 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $978,075 | 1,863 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,146,687 | 1,808 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,354,139 | 1,901 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,042,559 | 1,943 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,989,599 | 1,893 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,789,268 | 1,859 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,585,313 | 1,805 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,275,588 | 1,550 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,113,737 | 1,550 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,273,588 | 1,550 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,118,309 | 1,550 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,067,748 | 1,550 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $916,251 | 1,550 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,279,505 | 1,832 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $5,198,672 | 8,232 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $5,223,913 | 8,632 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,044,733 | 9,032 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,271,034 | 9,027 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $843,026 | 1,745 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $976,816 | 1,745 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $1,103,860 | 1,770 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $939,958 | 1,925 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||